ADVERSE EVENTS AND THE RELAPSE RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS DURING HYDROXYCHLOROQUINE TREATMENT

被引：0

作者：

Ichinose, Kunihiro ^{[1
]}

Fujikawa, Keita ^{[2
]}

Mizokami, Akinari ^{[2
]}

Aramaki, Toshiyuki ^{[3
]}

Ueki, Yukitaka ^{[3
]}

Eguchi, Mizuna ^{[1
]}

Okamoto, Momoko ^{[1
]}

Endo, Yushiro ^{[1
]}

Tsuji, Sousuke ^{[1
]}

Takatani, Ayuko ^{[1
]}

Shimizu, Toshimasa ^{[1
]}

Sumiyoshi, Remi ^{[1
]}

Koga, Tomohiro ^{[1
]}

Kawashiri, Shin-Ya ^{[1
]}

Iwamoto, Naoki ^{[1
]}

Igawa, Takashi ^{[1
]}

Tamai, Mami ^{[1
]}

Nakamura, Hideki ^{[1
]}

Origuchi, Tomoki ^{[4
]}

Kawakami, Atsushi ^{[1
]}

机构：

[1] Nagasaki Univ, Dept Immunol & Rheumatol, Unit Adv Prevent Med Sci, Grad Sch Biomed Sci, Nagasaki, Japan

[2] JCHO Isahaya Gen Hosp, Dept Rheumatol, Isahaya, Japan

[3] Sasebo Chuo Hosp, Ctr Rheumat Dis, Sasebo, Japan

[4] Nagasaki Univ, Dept Rehabil Sci, Grad Sch Biomed Sci, Nagasaki, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷

关键词：

D O I：

10.1136/annrheumdis-2019-eular.1171

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0466

引用

页码：1697 / 1697

页数：1

共 50 条

[1] Association of Hydroxychloroquine Dose With Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus
Jimenez, Alejandra Londono
Valle, Ana
Mustehsan, Mohammad Hashim
Wang, Shudan
Law, Jammie
Guerrero, Maria Salgado
Mowrey, Wenzhu B.
Horton, Daniel B.
Briceno, David
Broder, Anna
ARTHRITIS CARE & RESEARCH, 2023, : 1673 - 1680
[2] The Association of Hydroxychloroquine Dosing with Adverse Cardiovascular Events in Patients with Systemic Lupus Erythematosus
Jimenez, Alejandra Londono
Mustehsan, Mohammad Hashim
Valle, Ana
Law, Jammie
Wang, Shudan
Guerrero, Maria Auxiliadora Salgado
Briceno, David
Broder, Anna
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1806 - 1808
[3] HYDROXYCHLOROQUINE BLOOD LEVELS AND RISK OF THROMBOTIC EVENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Petri, M. A.
Konig, M.
Li, J.
Goldman, D.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 100 - 101
[4] Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
Grimaldi, Lamiae
Duchemin, Tom
Hamon, Yann
Buchard, Albert
Benichou, Jacques
Abenhaim, Lucien
Costedoat-Chalumeau, Nathalie
Moride, Yola
JAMA NETWORK OPEN, 2024, 7 (08)
[5] Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients
Kishi, Chikako
Motegi, Sei-ichiro
Yasuda, Masahito
Ishikawa, Osamu
JOURNAL OF DERMATOLOGY, 2018, 45 (08): : 1020 - 1022
[6] Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events
Smilowitz, Nathaniel R.
Katz, Gregory
Buyon, Jill P.
Clancy, Robert M.
Berger, Jeffrey S.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 13 - 17
[7] Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events
Nathaniel R. Smilowitz
Gregory Katz
Jill P. Buyon
Robert M. Clancy
Jeffrey S. Berger
Journal of Thrombosis and Thrombolysis, 2018, 45 : 13 - 17
[8] Hydroxychloroquine Dose and the Risk of Systemic Lupus Erythematosus Flares
Jorge, April
Mancini, Christian
Fu, Xiaoqing
Ho, Gary
Zhang, Yuqing
Costenbader, Karen
Choi, Hyon K.
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3070 - 3072
[9] Hydroxychloroquine Dose and Risk of Systemic Lupus Erythematosus Flares
Caravaca-Fontan, Fernando
Yandian, Federico
Fervenza, Fernando C.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (08): : 685 - 686
[10] Hydroxychloroquine in systemic lupus erythematosus
Costedoat-Chalumeau, Nathalie
Amoura, Zahir
Hulot, Jean-Sebastien
Lechat, Philippe
Piette, Jean-Charles
LANCET, 2007, 369 (9569): : 1257 - 1258

← 1 2 3 4 5 →